Cargando…

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression

Metastatic prostate cancer is a leading cause of cancer-related death in men worldwide. We have recently discovered that IL-30 shapes the microenvironment of prostate cancer and tumor-draining lymph nodes to favor tumor progression. IL-30 supports tumor growth in vitro, and IL-30 expression in prost...

Descripción completa

Detalles Bibliográficos
Autor principal:	Di Carlo, Emma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988120/ https://www.ncbi.nlm.nih.gov/pubmed/24741467 http://dx.doi.org/10.4161/onci.27618

Ejemplares similares

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

The role of interleukin-10 in the progression of human papillomavirus-associated lung carcinoma
por: Sung, Wen-Wei, et al.
Publicado: (2013)

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9(®) to better battle prostate cancer progression
por: Izumi, Kouji, et al.
Publicado: (2013)

Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
por: Kesselring, Rebecca, et al.
Publicado: (2012)

USP30: protector of peroxisomes and mitochondria
por: Riccio, Victoria, et al.
Publicado: (2019)

High-density lipoproteins delivering interleukin-15
por: Ochoa, Maria C., et al.
Publicado: (2013)

The novel partnership of L-GILZ and p53: a new affair in cancer?
por: Ayroldi, Emira, et al.
Publicado: (2014)

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
por: Fernandez Botana, Iria, et al.
Publicado: (2023)

Emerging roles of ATF3 in the suppression of prostate cancer
por: Wang, Ziyan, et al.
Publicado: (2015)

When fat goes down, prostate cancer is on the ropes
por: Zadra, Giorgia, et al.
Publicado: (2019)

Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition
por: Codarri Deak, Laura, et al.
Publicado: (2023)

Prostate cancer: Important steps and considerations in the design of therapeutic vaccines
por: McArdle, Stephanie EB, et al.
Publicado: (2014)

Opposing effects of androgen ablation on immune function in prostate cancer
por: Tang, Shuai, et al.
Publicado: (2012)

Battling the two-headed dragon of prostate cancer targeted therapy
por: Wilkinson, Scott, et al.
Publicado: (2020)

Metagenomic insights into the plasma virome of Brazilian patients with prostate cancer
por: Luciola Zanette, Dalila, et al.
Publicado: (2023)

Interleukin-2 treatment of tumor patients can expand regulatory T cells
por: Beyer, Marc
Publicado: (2012)

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients
por: Madan, Ravi A, et al.
Publicado: (2014)

Comparative lineage tracing reveals cellular preferences for prostate cancer initiation
por: Wang, Zhu A, et al.
Publicado: (2015)

Untargeted metabolomics for profiling oncogene-specific metabolic signatures of prostate cancer
por: Priolo, Carmen, et al.
Publicado: (2015)

Altering the intratumoral localization of macrophages to inhibit cancer progression
por: Casazza, Andrea, et al.
Publicado: (2014)

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis
por: Bastid, Jérémy, et al.
Publicado: (2014)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

Role of c-MYC in tumor-associated macrophages and cancer progression
por: Pello, Oscar M., et al.
Publicado: (2013)

Mechano-regulation of proline metabolism and cancer progression by kindlin-2
por: Guo, Ling, et al.
Publicado: (2019)

HIF-1 suppresses lipid catabolism to promote cancer progression
por: Zhang, Huafeng
Publicado: (2015)

ZMYND8 is a primary HIF coactivator that mediates breast cancer progression
por: Chen, Yan, et al.
Publicado: (2018)

Oncogenic regulatory circuits driven by 19q13 rs11672691 underlies prostate cancer aggressiveness
por: Xia, Ji-Han, et al.
Publicado: (2018)

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer
por: Thompson, Timothy C., et al.
Publicado: (2017)

Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012)

PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN
por: Gupta, Amit, et al.
Publicado: (2017)

Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression
por: Demers, Mélanie, et al.
Publicado: (2013)

Novel function of STAT1 in breast cancer
por: Zhang, Ming
Publicado: (2013)

A novel strategy for modulation of MDSC to enhance cancer immunotherapy
por: Ghansah, Tomar
Publicado: (2012)

mTORC1-driven accumulation of the oncometabolite fumarate as a potential critical step in renal cancer progression
por: Drusian, Luca, et al.
Publicado: (2018)

Are redox changes a critical switch for mitotic progression?
por: Lim, Daniel C., et al.
Publicado: (2020)

G3BP1 modulates SPOP to promote prostate tumorigenesis
por: Mukhopadhyay, Chandrani, et al.
Publicado: (2022)

β-endorphin neuron transplantation: A possible novel therapy for cancer prevention
por: Zhang, Changqing, et al.
Publicado: (2012)

Lung specific X protein as a novel therapeutic target for lung cancer
por: Zheng, Xiaohu, et al.
Publicado: (2015)

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity
por: Chandler, Benjamin C., et al.
Publicado: (2020)

REG3β contributes to the immunosuppressive microenvironment of pancreatic cancer
por: Folch-Puy, Emma
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ufs3ld4oabvbdlunmalq9q413b